| 發表論文 | Peer-Reviewed Original Research Articles
- Development and Validation of a Nomogram for Assessing Survival in Patients with Metastatic Lung Cancer Referred for Radiotherapy
for Bone Metastases. JAMA Network Open. 2018;1(6):e183242. (2020 JIF: 8.483, Cited by: 17)
Authors: Yap WK, Shih MC, Kuo C, Pai PC, Chou WC, Chang KP, Tsai MH, Tsang NM*. - Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy. European Journal of Nuclear Medicine and Molecular Imaging. 2018 May;45(5):689-698. (2020 JIF: 9.236, Cited by: 10)
Authors: Yap WK,Chang YC, Hsieh CH, Chao YK, Chen CC, Shih MC, Hung TM*. - Optimal Timing for Postsurgical Adjuvant Therapy in Patients with Gastric Cancer: A Propensity Score Matching Study. J Cancer 2019; 10(2):332-340. (2020 JIF: 4.207, Cited by: 8)
Authors: Huang SM, Chen YC, Chen WY, Yang LY, Tsan DL, Tsang NM, Yap WK, Tsai CS, Leung WM, Hong JH, Chang JTC, Yeh TS, Wu TH, Chen YC, Lin YH, Huang BS*. - Predictive value of nodal maximum standardized uptake value of pretreatment [18F] fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer. Dis Esophagus. 2017 Aug 1;30(8):1-10.(2020 JIF: 3.429, Cited by: 6)
Authors: Yap WK, Chang YC, Tseng CK, Hsieh CH, Chao YK, Su PJ, Hou MM, Yang CK, Pai PC, Lin CR, Hsieh CE, Wu YY, Hung TM*. - Prognostic Value of Lymph Node-To-Primary Tumor Standardized Uptake Value Ratio in Esophageal Squamous Cell Car-cinoma Treated with Definitive Chemoradiotherapy. Cancers 2020, 12, 607. (2020 JIF: 6.639, Cited by: 4)
Authors: Lin CH, Hung TM, Chang YC, Hsieh CH, Shih MC, Huang SM, Yang CK, Chang CF, Chan SC, Yap WK*. - Outcomes in patients with lacrimal gland carcinoma treated with definitive radiotherapy or eye-sparing surgery followed by adjuvant radiotherapy. Radiat Oncol 15, 156 (2020). (2020 JIF: 3.481, Cited by: 3)
Authors: Lin YH, Huang SM, Yap WK, Yang JW, Yeung L, Tsan DL, Chang TJ, Chen LC. - Prognostic value of lymph node to primary tumor standardized uptake value ratio in unresectable esophageal cancer. BMC Cancer 20, 545 (2020). (2020 JIF: 4.430, Cited by: 2)
Authors: Chen PJ, Yap WK, Chang YC, Tseng CK, Chao YK, Hsieh CH, Pai PC, Lee CH, Yang CK, Ho TY, Hung TM. - Missed radiation therapy sessions in first three weeks predict distant metastasis and less favorable outcomes in surgically treated patients with oral cavity squamous cell carcinoma. Radiat Oncol 15, 194 (2020). (2020 JIF: 3.481, Cited by: 1)
Authors: Chiang YY, Chou YC, Chang KP, Liao CT, Wu YY, Yap WK, Pai PC, Chang TC, Lin CY, Fan KH, Huang BS, Hung TM, Tsang NM. - Treatment outcome in patients with locally advanced gastric cancer receiving adjuvant chemoradiotherapy. Therapeutic Ra-diology and Oncology. 2017;24-1:1-1
Authors: Huang SM, Chen YC, Leung WM, Tsai CS, Fan KH, Hung TM, Yap WK, BS Huang*.
Oral Presentations at International Conferences
- Taiwan Joint Cancer Conference 2016
- The 6th Japan-Taiwan Radiation Oncology Symposium 2018
Poster Presentations at International Conferences
- Taiwan Joint Cancer Conference 2016
- American Society for Radiation Oncology (ASTRO) meeting 2016, at Boston, USA
- Taiwan Joint Cancer Conference 2017
- The 5th Japan-Taiwan Radiation Oncology Symposium 2017, at Kobe, Japan.
- European Society for Radiotherapy & Oncology (ESTRO) Conference 2018, at Barcelona, Spain.
- The 6th Japan-Taiwan Radiation Oncology Symposium 2018
- American Society for Radiation Oncology (ASTRO) meeting 2018, at San Antonio, USA
|
